{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T08:59:23Z","timestamp":1791622763044,"version":"4.3.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Med Ther"],"DOI":"10.1186\/s12906-025-05060-0","type":"journal-article","created":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:20:13Z","timestamp":1762874413000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Analysis of suspected serious adverse drug reactions reported with traditional medicines from the United Nations Asia region in WHO vigibase"],"prefix":"10.1186","volume":"25","author":[{"given":"Chandan","family":"N","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5285-8883","authenticated-orcid":false,"given":"Manish","family":"Barvaliya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tejas","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chetan","family":"AC","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9890-6745","authenticated-orcid":false,"given":"Harsha","family":"Hegde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Banappa","family":"Unger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,11]]},"reference":[{"key":"5060_CR1","unstructured":"European Medicines Agency. Guideline on good pharmacovigilance practices (GVP). 2017. https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/guideline-good-pharmacovigilance-practices-annex-i-definitions-rev-4_en.pdf. Accessed 23 Apr 2024."},{"key":"5060_CR2","unstructured":"US FDA. What is a Serious Adverse Event? 2023. https:\/\/www.fda.gov\/safety\/reporting-serious-problems-fda\/what-serious-adverse-event. Accessed 24 Apr 2024."},{"issue":"4","key":"5060_CR3","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1007\/s11096-018-0711-z","volume":"40","author":"P Baldo","year":"2018","unstructured":"Baldo P, Francescon S, Fornasier G. Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminology. Int J Clin Pharm. 2018;40(4):748\u201353.","journal-title":"Int J Clin Pharm"},{"issue":"15","key":"5060_CR4","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1001\/jama.279.15.1200","volume":"279","author":"J Lazarou","year":"1998","unstructured":"Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998;279(15):1200\u20135.","journal-title":"JAMA"},{"issue":"2","key":"5060_CR5","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s00228-021-03214-w","volume":"78","author":"TK Patel","year":"2022","unstructured":"Patel TK, Patel PB, Bhalla HL, Kishore S. Drug-related deaths among inpatients: a meta-analysis. Eur J Clin Pharmacol. 2022;78(2):267\u201378.","journal-title":"Eur J Clin Pharmacol"},{"key":"5060_CR6","unstructured":"Uppsala Monitoring Centre. Pharmacovigilance communications glossary. https:\/\/who-umc.org\/pharmacovigilance-communications\/glossary\/. Accessed 24 Apr 2024."},{"issue":"3","key":"5060_CR7","doi-asserted-by":"publisher","first-page":"284","DOI":"10.4314\/ajtcam.v8i3.65276","volume":"8","author":"CN Fokunang","year":"2011","unstructured":"Fokunang CN, Ndikum V, Tabi OY, Jiofack RB, Ngameni B, Guedje NM, et al. Traditional medicine: past, present and future research and development prospects and integration in the national health system of Cameroon. Afr J Tradit Complement Altern Med. 2011;8(3):284\u201395.","journal-title":"Afr J Tradit Complement Altern Med"},{"key":"5060_CR8","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.jep.2014.07.017","volume":"158","author":"P Claeson","year":"2014","unstructured":"Claeson P. Requirements on efficacy of herbal medicinal products. J Ethnopharmacol. 2014;158:463\u20136.","journal-title":"J Ethnopharmacol"},{"key":"5060_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2021.112762","volume":"159","author":"N Ba\u015faran","year":"2022","unstructured":"Ba\u015faran N, Pasl\u0131 D, Ba\u015faran AA. Unpredictable adverse effects of herbal products. Food Chem Toxicol. 2022;159: 112762.","journal-title":"Food Chem Toxicol"},{"issue":"2","key":"5060_CR10","doi-asserted-by":"publisher","first-page":"138","DOI":"10.2174\/1574886317666220428125943","volume":"18","author":"K Sanghvi","year":"2023","unstructured":"Sanghvi K, Subraya CK, Pai V, Nanjundaiah ARHH, Kunhikatta V. Pharmacovigilance in herbal drugs: a challenge. Curr Drug Saf. 2023;18(2):138\u201342.","journal-title":"Curr Drug Saf"},{"issue":"3","key":"5060_CR11","doi-asserted-by":"publisher","first-page":"256","DOI":"10.4103\/0975-1483.83780","volume":"3","author":"P Wal","year":"2011","unstructured":"Wal P, Wal A, Gupta S, Sharma G, Rai A. Pharmacovigilance of herbal products in India. J Young Pharm. 2011;3(3):256\u20138.","journal-title":"J Young Pharm"},{"issue":"4","key":"5060_CR12","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3233\/JRS-130604","volume":"25","author":"O Awodele","year":"2013","unstructured":"Awodele O, Daniel A, Popoola TD, Salami EF. A study on pharmacovigilance of herbal medicines in Lagos West senatorial district, Nigeria. Int J Risk Saf Med. 2013;25(4):205\u201317.","journal-title":"Int J Risk Saf Med"},{"issue":"6","key":"5060_CR13","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s40264-022-01180-5","volume":"45","author":"FPAM van Hunsel","year":"2022","unstructured":"van Hunsel FPAM, van der Kooi D, van de Koppel S, Kroes BH, Woerdenbag HJ. Analysis of reports on adverse drug reactions related to herbal medicinal products and herbal supplements in the Netherlands received by the National pharmacovigilance centre Lareb. Drug Saf. 2022;45(6):651\u201361.","journal-title":"Drug Saf"},{"key":"5060_CR14","unstructured":"Caveat, Document. May: Statement of reservations, limitations and conditions relating to data released from VigiBase, the WHO global database of reported potential side effects of medicinal products. https:\/\/who-umc.org\/media\/yzpnzmdv\/umc_caveat.pdf. Accessed 6 2024."},{"key":"5060_CR15","unstructured":"Medicinal Plant Names Services. https:\/\/mpns.science.kew.org\/mpns-portal\/. Accessed 6 May 2024."},{"key":"5060_CR16","unstructured":"Medical Dictionary for Regulatory Activities. MedDRA hierarchy. https:\/\/www.meddra.org\/how-to-use\/basics\/hierarchy. Accessed 6 May 2024."},{"key":"5060_CR17","unstructured":"Uppsala Monitoring Centre. vigiMethods. https:\/\/who-umc.org\/research\/vigimethods\/. Accessed 6 May 2024."},{"issue":"4","key":"5060_CR18","doi-asserted-by":"publisher","first-page":"339","DOI":"10.2165\/11586590-000000000-00000","volume":"34","author":"S Saokaew","year":"2011","unstructured":"Saokaew S, Suwankesawong W, Permsuwan U, Chaiyakunapruk N. Safety of herbal products in Thailand: an analysis of reports in the Thai health product vigilance center database from 2000 to 2008. Drug Saf. 2011;34(4):339\u201350.","journal-title":"Drug Saf"},{"issue":"1","key":"5060_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-00704-w","volume":"11","author":"HH Chang","year":"2021","unstructured":"Chang HH, Chiang SY, Chen PC, Tsai CH, Yang RC, Tsai CL, et al. A system for reporting and evaluating adverse drug reactions of herbal medicine in Taiwan from 1998 to 2016. Sci Rep. 2021;11(1): 21476.","journal-title":"Sci Rep"},{"key":"5060_CR20","unstructured":"Countrymeters A. 2024. https:\/\/countrymeters.info\/en\/Asia. Accessed 17 May 2024."},{"issue":"5","key":"5060_CR21","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1046\/j.1365-2133.2000.03822.x","volume":"143","author":"E Ernst","year":"2000","unstructured":"Ernst E. Adverse effects of herbal drugs in dermatology. Br J Dermatol. 2000;143(5):923\u20139.","journal-title":"Br J Dermatol"},{"issue":"3","key":"5060_CR22","first-page":"5","volume":"8","author":"RB Vender","year":"2003","unstructured":"Vender RB. Adverse reactions to herbal therapy in dermatology. Skin Therapy Lett. 2003;8(3):5\u20138.","journal-title":"Skin Therapy Lett"},{"key":"5060_CR23","doi-asserted-by":"publisher","first-page":"1088841","DOI":"10.3389\/fphar.2023.1088841","volume":"14","author":"MJ Barvaliya","year":"2023","unstructured":"Barvaliya MJ, Chetan AC, Chandan N, Ray SK, Hegde HV, Unger BS, et al. Suspected cutaneous adverse drug reactions reported with tms: analysis of data for united nations Asia region from WHO vigibase. Front Pharmacol. 2023;14:1088841.","journal-title":"Front Pharmacol"},{"issue":"1","key":"5060_CR24","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s00204-019-02621-4","volume":"94","author":"J Zhu","year":"2020","unstructured":"Zhu J, Chen M, Borlak J, Tong W. The landscape of hepatobiliary adverse reactions across 53 herbal and dietary supplements reveals immune-mediated injury as a common cause of hepatitis. Arch Toxicol. 2020;94(1):273\u201393.","journal-title":"Arch Toxicol"},{"issue":"6","key":"5060_CR25","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1007\/s12072-021-10241-3","volume":"15","author":"YS Huang","year":"2021","unstructured":"Huang YS, Chang TT, Peng CY, Lo GH, Hsu CW, Hu CT, et al. Herbal and dietary supplement-induced liver injury in Taiwan: comparison with conventional drug-induced liver injury. Hepatol Int. 2021;15(6):1456\u201365.","journal-title":"Hepatol Int"},{"issue":"5","key":"5060_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17050588","volume":"17","author":"C Frenzel","year":"2016","unstructured":"Frenzel C, Teschke R. Herbal hepatotoxicity: clinical characteristics and listing compilation. Int J Mol Sci. 2016;17(5): 588.","journal-title":"Int J Mol Sci"},{"issue":"9","key":"5060_CR27","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1097\/MEG.0b013e3283603e89","volume":"25","author":"R Teschke","year":"2013","unstructured":"Teschke R, Schulze J, Schwarzenboeck A, Eickhoff A, Frenzel C. Herbal hepatotoxicity: suspected cases assessed for alternative causes. Eur J Gastroenterol Hepatol. 2013;25(9):1093\u20138.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"1","key":"5060_CR28","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/apt.12109","volume":"37","author":"C Bunchorntavakul","year":"2013","unstructured":"Bunchorntavakul C, Reddy KR. Review article: herbal and dietary supplement hepatotoxicity. Aliment Pharmacol Ther. 2013;37(1):3\u201317.","journal-title":"Aliment Pharmacol Ther"},{"key":"5060_CR29","doi-asserted-by":"publisher","first-page":"962095","DOI":"10.3389\/fphar.2022.962095","volume":"13","author":"Y Yao","year":"2022","unstructured":"Yao Y, Habib M, Bajwa HF, Qureshi A, Fareed R, Altaf R, et al. Herbal therapies in gastrointestinal and hepatic disorders: an evidence-based clinical review. Front Pharmacol. 2022;13:962095.","journal-title":"Front Pharmacol"},{"key":"5060_CR30","doi-asserted-by":"publisher","DOI":"10.1007\/s11101-023-09910-y","author":"WJ Wei","year":"2024","unstructured":"Wei WJ, Guo T, Xue GM, Ma R, Wang Y, Chen ZS. Artemisia argyi H. L\u00e9v. & vaniot: a comprehensive review on traditional uses, phytochemistry, and pharmacological activities. Phytochem Rev. 2024. https:\/\/doi.org\/10.1007\/s11101-023-09910-y.","journal-title":"Phytochem Rev"},{"key":"5060_CR31","first-page":"8288818","volume":"2022","author":"N-E-T Das","year":"2022","unstructured":"Das N-E-T, Lami R, Chakraborty MS, Mitra AJ, Tallei S. Ginkgo biloba: A treasure of functional phytochemicals with multimedicinal applications. Evid Based Complement Alternat Med. 2022;2022:8288818.","journal-title":"Evid Based Complement Alternat Med"},{"issue":"9","key":"5060_CR32","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1002\/ptr.5644","volume":"30","author":"M Nassiri-Asl","year":"2016","unstructured":"Nassiri-Asl M, Hosseinzadeh H. Review of the pharmacological effects of vitis vinifera (grape) and its bioactive constituents: an update. Phytother Res. 2016;30(9):1392\u2013403.","journal-title":"Phytother Res"},{"issue":"3","key":"5060_CR33","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S2222-1808(14)60509-0","volume":"4","author":"A Okhuarobo","year":"2014","unstructured":"Okhuarobo A, Falodun JE, Erharuyi O, Imieje V, Falodun A, Langer P. Harnessing the medicinal properties of andrographis paniculata for diseases and beyond: a review of its phytochemistry and pharmacology. Asian Pac J Trop Dis. 2014;4(3):213\u201322.","journal-title":"Asian Pac J Trop Dis"},{"issue":"4","key":"5060_CR34","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1007\/s12325-020-01251-y","volume":"37","author":"A Gillessen","year":"2020","unstructured":"Gillessen A, Schmidt HH. Silymarin as supportive treatment in liver diseases: a narrative review. Adv Ther. 2020;37(4):1279\u2013301.","journal-title":"Adv Ther"},{"issue":"4","key":"5060_CR35","doi-asserted-by":"publisher","first-page":"151","DOI":"10.4103\/0257-7941.107344","volume":"31","author":"S Saha","year":"2012","unstructured":"Saha S, Ghosh S. Tinospora cordifolia: one plant, many roles. Anc Sci Life. 2012;31(4):151\u20139.","journal-title":"Anc Sci Life"}],"container-title":["BMC Complementary Medicine and Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-025-05060-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12906-025-05060-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-025-05060-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:20:20Z","timestamp":1762874420000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/s12906-025-05060-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,11]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5060"],"URL":"https:\/\/doi.org\/10.1186\/s12906-025-05060-0","relation":{},"ISSN":["2662-7671"],"issn-type":[{"value":"2662-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,11]]},"assertion":[{"value":"16 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have analyzed anonymized secondary data from VigiBase, obtained with due formalities and an agreement with the WHO Uppsala Monitoring Center, Sweden. Therefore, an ethics review was exempted for this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All the authors have read the manuscript and approved the content of this manuscript. Manuscript contains anonymized secondary data in form of aggregative analysis hence, consent from participants do not require.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"AC was affiliated with ICMR-NITM, Belagavi at the time of work planning and when the work was initiated, however, he is currently affiliated to Novartis Healthcare Private Limited, India. We declare that this work has been done in the absence of any commercial or financial interests that may have any potential conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"424"}}